The pharmaceutical industry is one of the key contributors to the Spanish economy. In 2019, the industry generated a revenue of almost 22 billion euros. Spain has, in fact, the fifth-largest pharmaceutical market in Europe in terms of revenue and the ninth-largest market worldwide. In 2020, the country exported 12.25 billion euros worth of pharmaceutical products, mainly to Switzerland, Germany, and France. The value of imported pharmaceuticals was 15.33 billion euros. Germany, the Netherlands, and Belgium were the main exporters of pharmaceutical products to Spain.
In Spain, the pharmaceutical sector spends more than any other industry on research and development. In 2019, pharmaceutical R&D amounted to 1.21 billion euros, the highest amount registered in recent years. Clinical research occupied the largest share of pharmaceutical R&D expenditure with approximately 714 million euros invested, followed by basic research, pharmacoeconomics, epidemiology, and post-authorization studies.
In 2018, Spain registered 124 companies in the manufacture of basic pharmaceutical products and 205 in the manufacture of pharmaceutical preparations. Many global pharmaceutical giants such as Pfizer, Novartis, Lilly, and Sanofi, among others, have subsidiaries in the Mediterranean country. Of these, Lilly and Novartis generated the highest revenues in 2019, with more than 1.7 and 1.1 billion euros, respectively. Among Spanish companies, the multinational Grifols, Laboratorios Cinfa, Laboratorios Esteve, and Almirall stand out.
This text provides general information. Statista assumes no
liability for the information given being complete or correct.
Due to varying update cycles, statistics can display more up-to-date
data than referenced in the text.
In the following 6 chapters, you will quickly find the 35 most important statistics relating to "Pharmaceutical industry in Spain".